in addition , other studies provided the evidence that both parenteral ( 800 mg/day ) and oral same ( 1600 mg/day ) significantly improves subjective ( pruritus , fatigue , and general discomfort ) and objective ( serum total and conjugated bilirubin , and serum alkaline phosphatase ) parameters of cholestasis in patients with intrahepatic cholestasis complicating chronic liver diseases compared with placebo .
C0008370
cholestasis
C0008372
intrahepatic cholestasis